Abstract
Breast cancer is the most common type of malignancy affecting women worldwide and also stands being the most diagnosed one. Mammography is considered as the golden standard for diagnosis but there are high chances that it can give false- negative as well as false-positive test results. Finding cost-effective, readily available diagnosis along with increased sensitivity as well as specificity is the need right now to decrease the mortality as well as the morbidity rate. The application of biomarkers to clinical use has paved the way for a better prognosis, diagnosis, detection, screening and better clinical results. The efficacy of the treatment is enhanced. Biomarkers are known to cause an advancement in breast cancer study and are expected to improve the quality of life in patients. Not only tissue biomarkers but serum and circulating biomarkers are also of significance in patients. This review highlights the particulars about the current use and application of biomarkers in an effective prognosis, detection, treatment of the breast cancer and also the ones which are currently being studied under clinical trials and have the potential to be advantageous and more specific in the future.
Keywords: Breast cancer, biomarkers, diagnosis, global, cytotoxic, screening.
Current Pharmaceutical Design
Title:Focus on the Multimodal Role of Biomarkers in Breast Cancer
Volume: 27 Issue: 35
Author(s): Damanpreet K. Lang, Ankita Sood, Rajwinder Kaur*, Rashmi Arora and Tapan Behl*
Affiliation:
- Chitkara College of Pharmacy, Chitkara University, Punjab,India
- Chitkara College of Pharmacy, Chitkara University, Punjab,India
Keywords: Breast cancer, biomarkers, diagnosis, global, cytotoxic, screening.
Abstract: Breast cancer is the most common type of malignancy affecting women worldwide and also stands being the most diagnosed one. Mammography is considered as the golden standard for diagnosis but there are high chances that it can give false- negative as well as false-positive test results. Finding cost-effective, readily available diagnosis along with increased sensitivity as well as specificity is the need right now to decrease the mortality as well as the morbidity rate. The application of biomarkers to clinical use has paved the way for a better prognosis, diagnosis, detection, screening and better clinical results. The efficacy of the treatment is enhanced. Biomarkers are known to cause an advancement in breast cancer study and are expected to improve the quality of life in patients. Not only tissue biomarkers but serum and circulating biomarkers are also of significance in patients. This review highlights the particulars about the current use and application of biomarkers in an effective prognosis, detection, treatment of the breast cancer and also the ones which are currently being studied under clinical trials and have the potential to be advantageous and more specific in the future.
Export Options
About this article
Cite this article as:
Lang K. Damanpreet, Sood Ankita , Kaur Rajwinder *, Arora Rashmi and Behl Tapan *, Focus on the Multimodal Role of Biomarkers in Breast Cancer, Current Pharmaceutical Design 2021; 27 (35) . https://dx.doi.org/10.2174/1381612827999210111185213
DOI https://dx.doi.org/10.2174/1381612827999210111185213 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) Treatment of Large Vessel Vasculitis
Current Immunology Reviews (Discontinued) (Section B: Integrated Function of Drug Transporters In Vivo) Drug Transport at the Blood-Brain Barrier and the Choroid Plexus
Current Drug Metabolism Recent Aspects of Osmotic Pump Systems: Functionalization, Clinical use and Advanced Imaging Technology
Current Drug Metabolism Neuroimaging Features of Acquired Metabolic and Toxic Encephalopathies
Current Medical Imaging Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Current Drug Abuse Reviews Myeloperoxidase: The Good, the Bad, and the Ugly
Current Immunology Reviews (Discontinued) Alpha-1 Antitrypsin: It’s Role in Health and Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery Single Photon Emission Tomography in the Diagnostic Assessment of Cardiac and Vascular Infectious Diseases
Current Radiopharmaceuticals Relevance of Protein Isoforms in Proteomic Studies
Current Proteomics Alcohol and the Cardiovascular System: A Double-Edged Sword
Current Pharmaceutical Design The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Spontaneous (Autoimmune) Chronic Urticaria in Children: Current Evidences, Diagnostic Pitfalls and Therapeutic Management
Recent Patents on Inflammation & Allergy Drug Discovery Familial Mediterranean Fever
Current Rheumatology Reviews Triggering Receptor Expressed on Myeloid Cells (TREM) Family and the Application of Its Antagonists
Recent Patents on Anti-Infective Drug Discovery Update on the Rheumatologic Manifestations of Malignancy
Current Cancer Therapy Reviews Cutaneous Lupus Erythematosus in Children
Current Pediatric Reviews The Role of Nitric Oxide on Endothelial Function
Current Vascular Pharmacology Modern Therapeutic Strategies for Autoimmune Diseases
Current Pharmaceutical Design